Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Walter Surowiec

Thoracic Surgery (Cardiothoracic Vascular Surgery) Gulfport, MS Doctor of Osteopathy

NPI 1134142821 CMS profile 50859

1340 Broad Ave, Ste 420, Gulfport, MS 39501

Open in the dashboard

General payments

$12,072

177 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Walter Surowiec of Gulfport, MS is reported in the CMS Open Payments database as having received $12,072 across 177 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,420 41
2024 General $759 22
2023 General $1,103 32
2022 General $6,714 34
2021 General $1,182 33
2020 General $745 12
2019 General $149 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Walter Surowiec
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Walter Surowiec were reported at $1,420. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Walter Surowiec Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $149 $886 $178–$3,167 $163
2020 $745 $341 $108–$1,605 $114
2021 $1,182 $453 $125–$1,886 $132
2022 $6,714 $695 $180–$2,566 $149
2023 $1,103 $745 $205–$2,662 $160
2024 $759 $799 $214–$2,967 $164
2025 $1,420 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $6,629 16 payments
  2. Ethicon US, LLC $1,520 43 payments
  3. Baxter Healthcare $1,105 12 payments
  4. Abiomed $709 24 payments
  5. Edwards Lifesciences Corporation $396 7 payments
  6. KLS-Martin L.P. $331 20 payments
  7. Atricure, Inc. $267 4 payments
  8. Janssen Pharmaceuticals, Inc $152 10 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $134 8 payments
  10. Philips Electronics North America Corporation $101 2 payments
  11. Other $728 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,134 165 payments
  2. Education $4,620 2 payments
  3. Travel and Lodging $2,318 10 payments
Products named General payments · program years 2019–2025
  1. DAVINCI XI $4,500 1 payment
  2. Da Vinci Surgical System $2,129 15 payments
  3. VISTASEAL $593 17 payments
  4. Echelon; Endopath $519 14 payments
  5. COSEAL $439 5 payments
  6. Impella $400 11 payments
  7. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $350 5 payments
  8. TISSEEL $272 3 payments
  9. N/A $196 7 payments
  10. PERCLOT $178 2 payments
  11. Other $1,975 71 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$81,721

Medicare's payments for the services billed

Medicare patients

105

Average age 75

Services billed

258

45 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 59%
Arthritis 50%
Diabetes 47%
Chronic kidney disease 43%
Atrial fibrillation 40%
COPD 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LEQVIO
  • Novartis Pharmaceuticals Corporation $43
$43 — —
Repatha
  • Amgen Inc. $29
$29 — —
Wegovy
  • Novo Nordisk Inc $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

177 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record